The trail enrolled 123 patients at 23 sites across the US and Europe.

Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the c ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control TM to bring the precision and ...

Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.

Jupiter Endovascular completes enrollment in a pivotal trial of its Vertex system with Transforming Fixation technology for pulmonary embolectomy.

Round Led by Sonder Capital with Participation from Senvest Management, LB Investment, and a New Strategic Corporate Investor MENLO PARK, Calif.--(BUSINESS WIRE)-- Jupiter Endovascular, Inc., a ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular interventions using its proprietary Transforming Fixation (TFX) ...

Medical technology startup Jupiter Endovascular has closed on a round of Series B funding, surpassing its $40 million goal. The funding was led by investor group Sonder Capital, which has also ...

400 Frames/S Saline-Flush OCT Human Imaging With AI-Based Automatic Pullback (Raywatt) Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is ...

Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using its proprietary Transforming Fixation (TFX) technology, today announced it has closed ...